Short Summary
The court passed an order disposing of several applications filed by both parties. The existing interim injunction was confirmed, and the defendant was permitted to sell their existing stock of 'DYFIRA' under specific conditions. This permission required the defendant to furnish a bank guarantee of Rs.30 lacs to secure potential damages.
Detailed Summary
Trademark battles are often painted as black-and-white fights where the winner gets everything and the loser gets nothing. But real-world disputes rarely fit such neat narratives. When a court injunction threatens to lock away inventory that is slowly losing its value, the law must grapple with a harder question: how do you protect a brand without destroying perfectly legitimate commercial value? The Biogen International Gmbh dispute offers a fascinating window into this tension.
Biogen International Gmbh, the plaintiff, found itself in a trademark conflict with Jayesh Shah, the defendant, over the mark 'DYFIRA.' The dispute had escalated to the point where Biogen sought court intervention to protect its brand, and an interim injunction had already been granted in its favor. However, the defendant was sitting on existing stock of goods bearing the 'DYFIRA' mark, stock that was subject to the injunction and could not be freely sold. Multiple applications were filed by both sides, each seeking to advance their respective positions in the ongoing conflict.
On one side stood Biogen, arguing for the strict enforcement of the interim injunction to prevent any further circulation of goods under the disputed mark. On the other side, Jayesh Shah faced a commercial reality: the existing stock of 'DYFIRA' was not infinite, and inventory left unsold would inevitably deteriorate in value or become unsellable altogether. The defendant sought relief that would allow him to monetize his existing legitimate stock without violating the court's protective order. The legal friction was clear: how could the court honor the injunction's intent while preventing the outright waste of existing inventory?
The court disposed of the various applications pending before it and confirmed the existing interim injunction, preserving Biogen's trademark protection. However, the court recognized the commercial reality facing the defendant and crafted a carefully balanced solution. Jayesh Shah was permitted to sell his existing stock of 'DYFIRA,' but only under specific conditions designed to safeguard Biogen's interests. Critically, the defendant was required to furnish a bank guarantee of Rs. 30 lacs to secure any potential damages that might arise from the sale. This order reflected the court's effort to honor the injunction's protective purpose while preventing the unnecessary destruction of commercial value tied up in existing inventory.
For founders and IP professionals, this case offers a powerful lesson in the practical realities of trademark enforcement. Winning an injunction is not the same as winning total victory, and courts will often look for ways to balance strict IP protection with legitimate commercial interests. If you are defending against an injunction, consider proactively proposing structured solutions, such as offering security or bank guarantees, that allow you to liquidate existing stock responsibly. If you are the brand owner seeking enforcement, anticipate that courts may permit limited, supervised sales of existing inventory, and build your litigation strategy around securing adequate financial guarantees rather than expecting a complete freeze on all related commerce.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in trademark matters before Delhi High Court - Orders. Understanding the court's reasoning in Biogen International Gmbh vs Jayesh Shah is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Mahesh Namkeen Pvt. Ltd.vsOm Prakash Nebhwani (Trading as: Mahesh Matar Namkeen)
Mahesh Namkeen Pvt. Ltd., a Lucknow-based company engaged in manufacturing namkeens and snacks since 1983 under the trademark 'MAHESH' (with parrot device), sued Om Prakash Nebhwani for trademark infringement and passing off. The defendant, who is the nephew of the plaintiff's director and had prior knowledge of the mark, adopted the identical 'MAHESH' mark with parrot/peacock device for his own namkeen business in Jaipur. The defendant's defense was struck off for non-filing of written statement. The court found the plaintiff's mark to be distinctive, well-established, and a well-known trademark, and held that the defendant's use constituted slavish copying amounting to infringement and passing off.
Ms Pas AgrovsM/S Krbl Limited & Anr
Ms Pas Agro has filed a petition under Section 124(1)(b)(ii) of the Trademarks Act challenging the Commercial Court's order dismissing its application to frame a preliminary issue on the invalidity of KRBL's registered trademark 'INDIA GATE' (application no. 599833). The underlying suit CS (COMM) 78/2025 was filed by KRBL against Pas Agro. The Delhi High Court issued notice, permitted deletion of respondent no.2, and granted time for filing reply and rejoinder. The substantive question of whether a preliminary issue on trademark invalidity should be framed remains pending.
Cryogas Equipment Private LimitedvsInox India Limited & Ors.
The Supreme Court disposed of a miscellaneous application seeking extension of time for the trial court to decide Trademark Suit No. 3 of 2019 between Cryogas Equipment Private Limited and Inox India Limited. As a last opportunity, the Court granted an additional six months to the concerned court to decide the suit, while expressly warning that no further extension would be entertained. The underlying dispute concerns trademark rights in the cryogenic/industrial gas equipment sector.
Mankind Consumer Products Private LimitedvsAlaina Healthcare Private Limited & A. Menarini India Private Limited
Mankind Consumer Products, the registered proprietor of the trademark ACNESTAR (Reg. No. 1352577 in Class 5) since 2005, sued Alaina Healthcare and A. Menarini India for using the marks ACNE SCAR/ACNE+SCAR/ACNESCAR on their acne scar serum product HEXILAK. The court found a prima facie case of deceptive similarity, noting that the dominant feature 'ACNE' was common and the suffix 'STAR' vs 'SCAR' was insufficient to distinguish the marks, especially given the identical trade channels and consumer class. The court granted an interim injunction in favour of the plaintiff while allowing defendant no. 2 a two-month period to recall existing stock from the trade.
Healthium Medtech Limited (earlier Healthium Medtech Private Limited)vsThe Registrar of Trade Marks, Chennai
Healthium Medtech Limited filed a writ petition seeking a mandamus to compel the Registrar of Trade Marks to expeditiously dispose of Opposition No. 1027536 filed by Glenmark Pharmaceuticals against Healthium's trademark application No. 4270882 for the 'Healthium' device mark in Classes 05 and 10. The petitioner complained that despite evidence having been adduced, the opposition proceedings remained pending without a final hearing. The Madras High Court allowed the writ petition and directed the Registrar to hear both parties and dispose of the opposition on merits within four weeks.
CavinKare Private LimitedvsMaha Aqua, Trading As Mahalakshmi Aqua
CavinKare Private Limited filed a trademark infringement suit against Maha Aqua (trading as Mahalakshmi Aqua) seeking a permanent injunction to restrain the defendant from using the mark 'MAA' or any deceptively similar mark in respect of goods in Class 32. The plaintiff relies on its registered trademarks 'MAA' under Nos. 1109946 and 6453733. The Court, after issues were framed and affidavits of admission/denial filed, approved a Joint Case Management Schedule suggested by both parties and set timelines for completion of evidence and oral arguments.
Facing a trademark dispute?
Arctic's TM litigation team handles ~120 trademark matters per year across India, EU, and UK. From oppositions to infringement actions, we build winning arguments from precedent.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.